Literature DB >> 1520595

Trends in mortality rates from malignant melanoma in Sweden 1953-1987 and forecasts up to 2007.

M Thörn1, P Sparén, R Bergström, H O Adami.   

Abstract

To monitor mortality rates from malignant melanoma we analysed all patients in Sweden (6,324) who died of malignant melanoma in 1953 through 1987. Age-standardised rates per 10(5) increased from 1.1 to 4.0 in men and from 1.0 to 2.6 in women. The average annual increase levelled off in men from 4.6% during 1953-1967 to 2.0% in 1978-1987; and in women from 3.7% to 0%. Multivariate analyses showed that the change in rates for men was mainly due to a birth-cohort effect, whereas in women the rates changed similarly in all age-groups in accordance with a time-period effect. The risk of dying of malignant melanoma increased in men for birth cohorts up to 1932, whereas in women the rise continued for cohorts born as late as 1947. The best-fitted multivariate models were extrapolated to the year 2007, among men a slight increase in mortality rates seemed likely, whereas among women the rates will probably remain unchanged.

Entities:  

Mesh:

Year:  1992        PMID: 1520595      PMCID: PMC1977942          DOI: 10.1038/bjc.1992.315

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  16 in total

1.  Changing trends in mortality from malignant melanoma.

Authors:  H M Shaw; W H McCarthy; G W Milton
Journal:  Med J Aust       Date:  1977-07-16       Impact factor: 7.738

2.  Models for temporal variation in cancer rates. I: Age-period and age-cohort models.

Authors:  D Clayton; E Schifflers
Journal:  Stat Med       Date:  1987-06       Impact factor: 2.373

3.  Using age, period and cohort models to estimate future mortality rates.

Authors:  C Osmond
Journal:  Int J Epidemiol       Date:  1985-03       Impact factor: 7.196

4.  Malignant melanoma. Changing trends in factors influencing metastasis-free survival from 1964 to 1982.

Authors:  K T Drzewiecki; H Frydman; K Andersen; H Poulsen; C Ladefoged; P Vibe
Journal:  Cancer       Date:  1990-01-15       Impact factor: 6.860

5.  Changing trends in cutaneous melanoma over a quarter century in Alabama, USA, and New South Wales, Australia.

Authors:  C M Balch; S J Soong; G W Milton; H M Shaw; V J McGovern; W H McCarthy; T M Murad; W A Maddox
Journal:  Cancer       Date:  1983-11-01       Impact factor: 6.860

6.  The thin malignant melanoma: changing patterns of epidemiology and treatment.

Authors:  R Shafir; J Hiss; H Tsur; J J Bubis
Journal:  Cancer       Date:  1982-08-15       Impact factor: 6.860

7.  An analysis of trends in mortality from malignant melanoma of the skin in Australia.

Authors:  C D Holman; I R James; P H Gattey; B K Armstrong
Journal:  Int J Cancer       Date:  1980-12-15       Impact factor: 7.396

8.  Temporal change in diagnostic criteria as a cause of the increase of malignant melanoma over time is unlikely.

Authors:  E P van der Esch; C S Muir; J Nectoux; G Macfarlane; P Maisonneuve; H Bharucha; J Briggs; R A Cooke; A G Dempster; W B Essex
Journal:  Int J Cancer       Date:  1991-02-20       Impact factor: 7.396

9.  The influence of age, year of birth, and date on mortality from malignant melanoma in the populations of England and Wales, Canada, and the white population of the United States.

Authors:  J A Lee; G R Petersen; R G Stevens; K Vesanen
Journal:  Am J Epidemiol       Date:  1979-12       Impact factor: 4.897

10.  Increasing survival trend after cancer diagnosis in Sweden: 1960-1984.

Authors:  H O Adami; P Sparén; R Bergström; L Holmberg; U B Krusemo; J Pontén
Journal:  J Natl Cancer Inst       Date:  1989-11-01       Impact factor: 13.506

View more
  2 in total

1.  Has mortality from melanoma stopped rising in Australia? Analysis of trends between 1931 and 1994.

Authors:  G G Giles; B K Armstrong; R C Burton; M P Staples; V J Thursfield
Journal:  BMJ       Date:  1996-05-04

2.  Trends in tumour characteristics and survival of malignant melanoma 1960-84: a population-based study in Sweden.

Authors:  M Thörn; F Pontén; R Bergström; P Sparén; H O Adami
Journal:  Br J Cancer       Date:  1994-10       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.